P6153High risk plaque by coronary CTA predict cardiac events but not all-cause mortality: long term follow up

Abstract Background Ultra long-term (10 years) outcome data of coronary computed tomography angiography (CTA) for coronary heart disease (CHD) screening are lacking. Novel CTA imaging biomarkers (“high-risk-plaque”) may improve risk stratification. Aims To define CT-imaging predictors for long–term...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European heart journal 2019-10, Vol.40 (Supplement_1)
Hauptverfasser: Senoner, T, Plank, F, Babieri, F, Dichtl, W, Beyer, C, Friedrich, G, Feuchtner, G M
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue Supplement_1
container_start_page
container_title European heart journal
container_volume 40
creator Senoner, T
Plank, F
Babieri, F
Dichtl, W
Beyer, C
Friedrich, G
Feuchtner, G M
description Abstract Background Ultra long-term (10 years) outcome data of coronary computed tomography angiography (CTA) for coronary heart disease (CHD) screening are lacking. Novel CTA imaging biomarkers (“high-risk-plaque”) may improve risk stratification. Aims To define CT-imaging predictors for long–term outcomes. Methods 1430 low-to-intermediate-risk patients (mean age 57.9 years; 44.4% females) were included into our prospective cohort study. Coronary Calcium Score (CCS) and CTA were performed. CTA was evaluated for: Stenosis severity (minimal
doi_str_mv 10.1093/eurheartj/ehz746.0759
format Article
fullrecord <record><control><sourceid>oup_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_eurheartj_ehz746_0759</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/eurheartj/ehz746.0759</oup_id><sourcerecordid>10.1093/eurheartj/ehz746.0759</sourcerecordid><originalsourceid>FETCH-LOGICAL-c879-62c18f0e09ede7f9eb9460c736f173d24db3710bef202f7e67589112ff6ce0dd3</originalsourceid><addsrcrecordid>eNqN0MtOwzAQhWELgUS5PALSvEBaOxc7ZldVQJEqwaILdpHjjNsUJw62AypPT6si1qxm9Y90PkLuGJ0yKrMZjn6LysfdDLffIudTKgp5RiasSNNE8rw4JxPKZJFwXr5dkqsQdpTSkjM-Id0rZ0W2bDdb8G14h8GqjxGh3oN23vXK72GxnsPgsWl1BK180yoN-Il9DFCPEXoXQVmbaDUGhM75qGwb9_dgXb-BiL4D46x1XzAON-TCKBvw9vdek_Xjw3qxTFYvT8-L-SrRpZAJTzUrDUUqsUFhJNYy51SLjBsmsibNmzoTjNZoUpoagVwUpWQsNYZrpE2TXZPi9FZ7F4JHUw2-7Q5bKkarI1n1R1adyKoj2aGjp86Nwz-TH62tdTU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>P6153High risk plaque by coronary CTA predict cardiac events but not all-cause mortality: long term follow up</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Senoner, T ; Plank, F ; Babieri, F ; Dichtl, W ; Beyer, C ; Friedrich, G ; Feuchtner, G M</creator><creatorcontrib>Senoner, T ; Plank, F ; Babieri, F ; Dichtl, W ; Beyer, C ; Friedrich, G ; Feuchtner, G M</creatorcontrib><description><![CDATA[Abstract Background Ultra long-term (10 years) outcome data of coronary computed tomography angiography (CTA) for coronary heart disease (CHD) screening are lacking. Novel CTA imaging biomarkers (“high-risk-plaque”) may improve risk stratification. Aims To define CT-imaging predictors for long–term outcomes. Methods 1430 low-to-intermediate-risk patients (mean age 57.9 years; 44.4% females) were included into our prospective cohort study. Coronary Calcium Score (CCS) and CTA were performed. CTA was evaluated for: Stenosis severity (minimal<25%; mild<50%; moderate 50–70%; severe >70%) (CADRADS 1–4), total mixed plaque burden (G-score), high–risk-plaque criteria: 1) low attenuation plaque 2) Napkin-ring (“lunar-eclipse” sign) 3) spotty calcification 4) remodeling index Primary endpoint was all-cause mortality, secondary endpoints cardiovascular mortality and composite (non-fatal and fatal) MACE. Results Over a follow-up of mean 10.55 years ±1.98 (range, 6.1–12.8), all-cause mortality rate was 106 (7.4%), cardiovascular mortality 25 (1.75%) and composite MACE 57 (4%). In patients with negative CTA, cardiovascular mortality was 0% and composite MACE rate 0.2%. Stenosis severity (CADRADS) was the strongest predictor for all 3 endpoints (p<0.001) on multivariate analysis (unadjusted and adjusted for risk factors, p<0.001) but calcium score >100 AU only predicted mortality on the unadjusted multivariate analysis (p=0.045) but not on the adjusted. On multivariate analysis, G-score (p<0.0001), LAP<60HU and the Napkin-Ring predicted composite MACE (p<0.001) but not all-cause mortality, before and after adjusting for risk factors (p=0.007 and 0.001 for LAP<60HU and Napkin-Ring, respectively) while spotty calcification and remodeling index did not. 465 had calcium score zero and in 156 (33.5%) of those, noncalcified fibroatheroma were found (total rate, 11%), 4.9% had >50% stenosis. However only 1 patient with calcium score zero died while there were 6 MACE. High risk plaque with “lunar eclipse” Conclusions Long-term prognosis is excellent if CTA is negative. Stenosis severity by CTA predicts all-cause and cardiovascular mortality, while calcium score predicts only mortality. Plaque burden and the high-risk plaque criteria LAP<60 and Napkin-Ring (syn. “lunar eclipse”) are strong predictors of MACE, but not all–cause mortality. Coronary CTA outperforms calcium scoring for risk stratification.]]></description><identifier>ISSN: 0195-668X</identifier><identifier>EISSN: 1522-9645</identifier><identifier>DOI: 10.1093/eurheartj/ehz746.0759</identifier><language>eng</language><publisher>Oxford University Press</publisher><ispartof>European heart journal, 2019-10, Vol.40 (Supplement_1)</ispartof><rights>Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: journals.permissions@oup.com. 2019</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,1578,27901,27902</link.rule.ids></links><search><creatorcontrib>Senoner, T</creatorcontrib><creatorcontrib>Plank, F</creatorcontrib><creatorcontrib>Babieri, F</creatorcontrib><creatorcontrib>Dichtl, W</creatorcontrib><creatorcontrib>Beyer, C</creatorcontrib><creatorcontrib>Friedrich, G</creatorcontrib><creatorcontrib>Feuchtner, G M</creatorcontrib><title>P6153High risk plaque by coronary CTA predict cardiac events but not all-cause mortality: long term follow up</title><title>European heart journal</title><description><![CDATA[Abstract Background Ultra long-term (10 years) outcome data of coronary computed tomography angiography (CTA) for coronary heart disease (CHD) screening are lacking. Novel CTA imaging biomarkers (“high-risk-plaque”) may improve risk stratification. Aims To define CT-imaging predictors for long–term outcomes. Methods 1430 low-to-intermediate-risk patients (mean age 57.9 years; 44.4% females) were included into our prospective cohort study. Coronary Calcium Score (CCS) and CTA were performed. CTA was evaluated for: Stenosis severity (minimal<25%; mild<50%; moderate 50–70%; severe >70%) (CADRADS 1–4), total mixed plaque burden (G-score), high–risk-plaque criteria: 1) low attenuation plaque 2) Napkin-ring (“lunar-eclipse” sign) 3) spotty calcification 4) remodeling index Primary endpoint was all-cause mortality, secondary endpoints cardiovascular mortality and composite (non-fatal and fatal) MACE. Results Over a follow-up of mean 10.55 years ±1.98 (range, 6.1–12.8), all-cause mortality rate was 106 (7.4%), cardiovascular mortality 25 (1.75%) and composite MACE 57 (4%). In patients with negative CTA, cardiovascular mortality was 0% and composite MACE rate 0.2%. Stenosis severity (CADRADS) was the strongest predictor for all 3 endpoints (p<0.001) on multivariate analysis (unadjusted and adjusted for risk factors, p<0.001) but calcium score >100 AU only predicted mortality on the unadjusted multivariate analysis (p=0.045) but not on the adjusted. On multivariate analysis, G-score (p<0.0001), LAP<60HU and the Napkin-Ring predicted composite MACE (p<0.001) but not all-cause mortality, before and after adjusting for risk factors (p=0.007 and 0.001 for LAP<60HU and Napkin-Ring, respectively) while spotty calcification and remodeling index did not. 465 had calcium score zero and in 156 (33.5%) of those, noncalcified fibroatheroma were found (total rate, 11%), 4.9% had >50% stenosis. However only 1 patient with calcium score zero died while there were 6 MACE. High risk plaque with “lunar eclipse” Conclusions Long-term prognosis is excellent if CTA is negative. Stenosis severity by CTA predicts all-cause and cardiovascular mortality, while calcium score predicts only mortality. Plaque burden and the high-risk plaque criteria LAP<60 and Napkin-Ring (syn. “lunar eclipse”) are strong predictors of MACE, but not all–cause mortality. Coronary CTA outperforms calcium scoring for risk stratification.]]></description><issn>0195-668X</issn><issn>1522-9645</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNqN0MtOwzAQhWELgUS5PALSvEBaOxc7ZldVQJEqwaILdpHjjNsUJw62AypPT6si1qxm9Y90PkLuGJ0yKrMZjn6LysfdDLffIudTKgp5RiasSNNE8rw4JxPKZJFwXr5dkqsQdpTSkjM-Id0rZ0W2bDdb8G14h8GqjxGh3oN23vXK72GxnsPgsWl1BK180yoN-Il9DFCPEXoXQVmbaDUGhM75qGwb9_dgXb-BiL4D46x1XzAON-TCKBvw9vdek_Xjw3qxTFYvT8-L-SrRpZAJTzUrDUUqsUFhJNYy51SLjBsmsibNmzoTjNZoUpoagVwUpWQsNYZrpE2TXZPi9FZ7F4JHUw2-7Q5bKkarI1n1R1adyKoj2aGjp86Nwz-TH62tdTU</recordid><startdate>20191001</startdate><enddate>20191001</enddate><creator>Senoner, T</creator><creator>Plank, F</creator><creator>Babieri, F</creator><creator>Dichtl, W</creator><creator>Beyer, C</creator><creator>Friedrich, G</creator><creator>Feuchtner, G M</creator><general>Oxford University Press</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20191001</creationdate><title>P6153High risk plaque by coronary CTA predict cardiac events but not all-cause mortality: long term follow up</title><author>Senoner, T ; Plank, F ; Babieri, F ; Dichtl, W ; Beyer, C ; Friedrich, G ; Feuchtner, G M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c879-62c18f0e09ede7f9eb9460c736f173d24db3710bef202f7e67589112ff6ce0dd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Senoner, T</creatorcontrib><creatorcontrib>Plank, F</creatorcontrib><creatorcontrib>Babieri, F</creatorcontrib><creatorcontrib>Dichtl, W</creatorcontrib><creatorcontrib>Beyer, C</creatorcontrib><creatorcontrib>Friedrich, G</creatorcontrib><creatorcontrib>Feuchtner, G M</creatorcontrib><collection>CrossRef</collection><jtitle>European heart journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Senoner, T</au><au>Plank, F</au><au>Babieri, F</au><au>Dichtl, W</au><au>Beyer, C</au><au>Friedrich, G</au><au>Feuchtner, G M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>P6153High risk plaque by coronary CTA predict cardiac events but not all-cause mortality: long term follow up</atitle><jtitle>European heart journal</jtitle><date>2019-10-01</date><risdate>2019</risdate><volume>40</volume><issue>Supplement_1</issue><issn>0195-668X</issn><eissn>1522-9645</eissn><abstract><![CDATA[Abstract Background Ultra long-term (10 years) outcome data of coronary computed tomography angiography (CTA) for coronary heart disease (CHD) screening are lacking. Novel CTA imaging biomarkers (“high-risk-plaque”) may improve risk stratification. Aims To define CT-imaging predictors for long–term outcomes. Methods 1430 low-to-intermediate-risk patients (mean age 57.9 years; 44.4% females) were included into our prospective cohort study. Coronary Calcium Score (CCS) and CTA were performed. CTA was evaluated for: Stenosis severity (minimal<25%; mild<50%; moderate 50–70%; severe >70%) (CADRADS 1–4), total mixed plaque burden (G-score), high–risk-plaque criteria: 1) low attenuation plaque 2) Napkin-ring (“lunar-eclipse” sign) 3) spotty calcification 4) remodeling index Primary endpoint was all-cause mortality, secondary endpoints cardiovascular mortality and composite (non-fatal and fatal) MACE. Results Over a follow-up of mean 10.55 years ±1.98 (range, 6.1–12.8), all-cause mortality rate was 106 (7.4%), cardiovascular mortality 25 (1.75%) and composite MACE 57 (4%). In patients with negative CTA, cardiovascular mortality was 0% and composite MACE rate 0.2%. Stenosis severity (CADRADS) was the strongest predictor for all 3 endpoints (p<0.001) on multivariate analysis (unadjusted and adjusted for risk factors, p<0.001) but calcium score >100 AU only predicted mortality on the unadjusted multivariate analysis (p=0.045) but not on the adjusted. On multivariate analysis, G-score (p<0.0001), LAP<60HU and the Napkin-Ring predicted composite MACE (p<0.001) but not all-cause mortality, before and after adjusting for risk factors (p=0.007 and 0.001 for LAP<60HU and Napkin-Ring, respectively) while spotty calcification and remodeling index did not. 465 had calcium score zero and in 156 (33.5%) of those, noncalcified fibroatheroma were found (total rate, 11%), 4.9% had >50% stenosis. However only 1 patient with calcium score zero died while there were 6 MACE. High risk plaque with “lunar eclipse” Conclusions Long-term prognosis is excellent if CTA is negative. Stenosis severity by CTA predicts all-cause and cardiovascular mortality, while calcium score predicts only mortality. Plaque burden and the high-risk plaque criteria LAP<60 and Napkin-Ring (syn. “lunar eclipse”) are strong predictors of MACE, but not all–cause mortality. Coronary CTA outperforms calcium scoring for risk stratification.]]></abstract><pub>Oxford University Press</pub><doi>10.1093/eurheartj/ehz746.0759</doi></addata></record>
fulltext fulltext
identifier ISSN: 0195-668X
ispartof European heart journal, 2019-10, Vol.40 (Supplement_1)
issn 0195-668X
1522-9645
language eng
recordid cdi_crossref_primary_10_1093_eurheartj_ehz746_0759
source Oxford University Press Journals All Titles (1996-Current); Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
title P6153High risk plaque by coronary CTA predict cardiac events but not all-cause mortality: long term follow up
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T17%3A29%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-oup_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=P6153High%20risk%20plaque%20by%20coronary%20CTA%20predict%20cardiac%20events%20but%20not%20all-cause%20mortality:%20long%20term%20follow%20up&rft.jtitle=European%20heart%20journal&rft.au=Senoner,%20T&rft.date=2019-10-01&rft.volume=40&rft.issue=Supplement_1&rft.issn=0195-668X&rft.eissn=1522-9645&rft_id=info:doi/10.1093/eurheartj/ehz746.0759&rft_dat=%3Coup_cross%3E10.1093/eurheartj/ehz746.0759%3C/oup_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_oup_id=10.1093/eurheartj/ehz746.0759&rfr_iscdi=true